Is a GLP-1 Right for Your Teen? How Families Can Decide on Weight-Management Medication

Whether a GLP-1 is right for your teen depends on your child's overall health, current lifestyle, and other factors, not just on weight alone. A GLP-1 is a type of weight-management medicine that works with your body's hunger signals, alongside lifestyle changes, to support your child's overall health. Like any medication, starting it is a decision you make together with your pediatrician, and it is often not a simple "yes or no." GLP-1 medicines like semaglutide are approved for some teens ages 12 and older who meet specific criteria, including a BMI at or above the 95th percentile for their age and sex, and they work best as one part of a full care plan that includes lifestyle and behavior changes.

Who are GLP-1 medications actually meant for?

GLP-1 medicines are meant for teens ages 12 and older who have obesity and meet key clinical criteria showing that weight is affecting their health. They should not be treated as a quick fix for any child who wants to lose weight.

Doctors define obesity as a body mass index (BMI) at or above the 95th percentile for a child's age and sex. In plain terms, that means a teen's weight falls in the top 5 percent compared with other kids the same age and sex. The decision also looks at the whole child, including any weight-related health conditions. A comorbidity is another health problem linked to weight, such as prediabetes, high blood pressure, or sleep apnea.

Two GLP-1-class medicines are FDA-approved for this age group:

Wegovy (semaglutide): a weekly injection, approved for ages 12 and older.

Saxenda (liraglutide): a daily injection, approved for ages 12 and older.

One drug you may have heard of is not approved for teens. Zepbound (tirzepatide) is approved only for adults. A study in teens is underway, but for now it is not an option for this age group.

Want the full eligibility picture? See our guide on who qualifies for teen obesity treatment and our GLP-1 telehealth hub for teens.

How should families decide if a GLP-1 is right for their child?

Families decide through shared decision-making. That means you, your teen, and your doctor discuss the benefits, risks, and your child's health together. It should never be a choice the doctor makes alone.

The American Academy of Pediatrics (AAP) is the leading voice on children's health. Its 2023 guideline says doctors should offer a weight-management medicine to teens 12 and older with obesity, as an add-on to lifestyle care and chosen together with the family.

An informed decision usually considers a few things at once:

• Your teen's full health, not just the number on the scale.
• How weight is affecting their quality of daily life and health right now.
• What lifestyle changes your family has already tried, and how it is going.
• How you and your teen feel about using a weekly, injected medicine.
• How you and your child understand both the benefits and the risks, including the most common side effects.

The goal is a well-made decision, whichever way it goes. Saying yes, saying not yet, or focusing on lifestyle first can all be the right call for a given teen and family.

What questions should I ask my pediatrician before starting?

Bring a clear list of questions to your visit. The right questions help you and your doctor make the decision together and set honest expectations.

Here are questions worth asking before your teen starts a GLP-1:

1. Is my child a candidate for this medicine, based on their full health picture?
2. Does anyone in our family have a history of medullary thyroid cancer or MEN 2? (This matters for safety.)
3. What benefits can we realistically expect, and how soon?
4. What side effects are most common, and how do we manage them?
5. What do we still not know about long-term safety in teens?
6. What happens if we stop the medicine later?
7. How will lifestyle care, like nutrition and activity, continue alongside it?
8. How often will my teen need check-ups, labs, and dose changes?
9. What will this cost us, including the medicine and the care around it?
10. Will insurance cover it, and if not, what are our options?
11. What are the signs that mean we should call you right away?

How do you weigh the benefits against the risks and unknowns?

Deciding on a GLP-1 means looking honestly at both sides. There are significant benefits for many teens, along with side effects and long-term unknowns that deserve careful thought. A trusted medical provider can help you weigh them for your child.

In simple terms, a GLP-1 works with a hormone your body already makes after you eat, so your teen feels full sooner and less hungry and smaller portions feel more satisfying. It is not a foreign chemical; it builds on a natural appetite signal your body already uses, and it works best alongside healthy eating, activity, and behavior changes.

What the benefits can look like

The benefits can be meaningful, and we have strong research in teens. In the largest teen study, called STEP TEENS, adolescents took weekly semaglutide (Wegovy) plus lifestyle support for about 16 months. On average, their BMI dropped about 16 percent over that time, and roughly 7 in 10 lost at least 5 percent of their body weight. Many also saw better blood pressure, blood sugar, and cholesterol numbers.

The study also showed that teens respond differently: some saw strong results at low doses, while others needed higher doses to change their BMI. So these numbers are averages, not promises. Every teen responds differently, so think of them as what results can look like, not what they will be. And remember, the medicine in this trial was used alongside lifestyle changes, not instead of them.

Side effects and what we still don't know long-term

Side effects are most commonly stomach-related, like nausea, diarrhea, and constipation, and they often ease over time. They are usually worse early in treatment and improve as the body adjusts. Diet quality matters too: meals high in sugar and fat tend to cause more side effects than meals high in fiber and protein. Doctors lower the risk by starting at a low dose and raising it slowly, based on how each teen responds. Most side effects are manageable, but a minority are serious enough to stop treatment: in the largest teen study, about 1 in 20 teens (5 percent) stopped because of stomach side effects, and about 4 percent developed gallstones. This is why close medical follow-up is an important part of treatment.

There are also rare but serious risks that a doctor screens for before starting treatment.

Doctors also watch for pancreas and gallbladder problems, dehydration from vomiting or diarrhea, and allergic reactions. Teens on Wegovy had somewhat higher rates of gallbladder issues, and of skin reactions like rash and hives, than adults, so these are worth asking about.

Now for the honest part. The longest teen weight-loss study lasted about 16 months, so there is no multi-year safety or durability data in teens using these medicines for weight loss yet. We do have longer-term safety data in teens who take these medicines for type 2 diabetes, where they have been used for years for other medical reasons. When the medicine is stopped, teens generally regain weight, though how much and how fast varies. In adults who stopped semaglutide, about two-thirds of the lost weight returned within a year, and early teen data shows the same pattern. Because of this, doctors treat obesity as a long-term condition, and a teen may need ongoing treatment to keep results.

Here is a simple way to hold both sides together:

Why is lifestyle and behavior care still the foundation?

Lifestyle and behavior change remains the foundation for healthy weight loss, because medicine is added on top of it, never in place of it. Quality nutrition, physical activity, sleep hygiene, and other behavioral supports are the basis for healthy, sustainable weight loss.

The AAP guidelines are clear: a weight-management medicine is an add-on to intensive lifestyle treatment, not a standalone fix. The CDC frames it the same way, with healthy behaviors at the center of successful weight loss. So if you are worried that a medicine means "giving up" on diet and exercise, the guidelines say the opposite. The medicine is an evidence-based tool that is medically indicated for many patients.

This is also why a comprehensive care program matters. With Blueberry Balance, nutrition coaching from a registered dietitian is built into the program, so families do not have to find one on their own. The medicine works best wrapped in that support, with regular follow-up and monitoring.

How do I talk to my teen about weight and GLP-1 medication?

Talking to your teen in a way that supports their autonomy and self-esteem is critically important. Focus on their health and how they feel, both physically and mentally, not on their appearance or blame for the issue. The words you use in starting the conversation can make a real difference in keeping them open to all treatment options.

The AAP also has clear guidance on this, because starting a conversation that is solely focused on weight or appearance can create tension and unnecessary resistance in your relationship. Shaming, teasing, or forcing decisions do not lead to healthy change or openness. These are often linked to worse outcomes, like disordered eating, avoiding care, lower self-image, and unhealthy eating patterns.

Here are some tips on how to keep the conversation teen-centered and supportive:

• Use teen-first language and put your teen in the driver's seat. Say, "I want you to be as healthy as you can be. How can we start this conversation in a way that feels comfortable for you?"
• Focus on health and feelings, not looks. Talk about energy, mood, and how their body feels.
• Ask permission before diving in, do not lecture. Use open-ended questions to invite your teen in, such as "Can we talk about this?" or "Is it okay if I share some of my thoughts?"
• Involve your teen in the decision. This is their body and their care, so their voice matters.
• Never frame this conversation as punishment or your child's fault. No one chooses to struggle with their weight; it is not about a lack of motivation or laziness. Weight is shaped by many things outside anyone's control, including genetics, biology, and environment.

The AAP and The Obesity Society advise using people-first, empathetic language rather than blame or shame when talking with children and teens about weight.

When might a GLP-1 not be the right choice?

A GLP-1 may not be the right step right now for several reasons, and that is okay. Qualifying for a medicine does not mean a family has to start it.

It may not be the right time if:

• Your teen has a personal or family history of medullary thyroid cancer or MEN 2, which is a clear reason to avoid these medicines.
• Your teen is pregnant, planning a pregnancy, or breastfeeding.
• Your family wants to focus on lifestyle change first and see how it goes.
• Your teen is not ready to start a long-term medication, and forcing it could create more stress or a difficult relationship with food.
• The practical pieces are not in place yet, like the ability to have steady follow-up, complete routine labs, and family support.

Deciding to wait is not a failure. It is a valid, careful choice. You can always revisit the conversation with your doctor as your teen's health and readiness change.

What does the decision process look like with a Blueberry Balance provider?

With a Blueberry Balance provider, the process is built around shared decision-making. The provider looks at your teen's full health, lays out the honest pros and cons, and helps your family decide together. Often, the decision to start a medication is driven by medical need: if your teen has weight-related health issues, our provider will explain how a GLP-1 can help address them.

A first visit usually covers your teen's whole health picture, not just their weight. Your provider will review your teen's health history, order screening labs, discuss lifestyle and mental health, and talk through the risks and benefits of the medications. They also surface questions families often miss, like family thyroid history and what happens if you stop abruptly. From there, you and your teen decide together whether to start, wait, or focus on lifestyle as a first step.

In our experience with Balance families, one of the most common worries parents share is a feeling of guilt. They wonder whether starting a medicine means they failed, or that they are "giving up" on diet and exercise. The honest answer is no. Just as no one would call starting medication for severe asthma or high blood pressure a personal failure, starting a GLP-1 is not a failure either. These medicines are valuable tools for improving health, and they work alongside your family's ongoing efforts, not in place of them.

An important note on cost of treatment, as access to these medications can be challenging and costly. The Blueberry Balance subscription is $149 a month and includes physician visits, dietitian visits, health coaching, and labs. Medication is a separate cost, starting at $199 a month as of July 2026, and depends on the drug, the dose, and your insurance. The program fee and the medicine are two different bills, never one combined price. For the full cost and coverage picture, see our guides on teen weight-loss medication cost and whether insurance covers GLP-1s for teens.

Frequently Asked Questions

Should my child take Wegovy?

That depends on your child's full health, not weight alone, and it is a decision you make with your pediatrician. Wegovy is approved for some teens 12 and older who have obesity, and it works best as one part of a full care plan.

At what age can a teen start a GLP-1?

Wegovy and Saxenda are FDA-approved for teens ages 12 and older who have obesity. Zepbound is not approved under 18.

Are GLP-1s (semaglutide and liraglutide) safe for teens?

These medicines are FDA-approved for teens 12 and older and have real benefits, but they carry side effects and long-term unknowns. For a fuller safety picture, see our GLP-1 telehealth hub for teens and our teen weight-loss medication overview.

Is using medication "giving up" on diet and exercise and other lifestyle changes?

Absolutely not. Current obesity science and recent pediatric guidelines agree that a weight-management medicine like a GLP-1 is a safe and effective part of weight management when combined with lifestyle changes, not a stand-alone treatment. In some teens, lifestyle change alone may not be enough to reach optimal health, and medication can lead to meaningful long-term health improvements. Nutrition, activity, and behavior support continue alongside it.

What happens if my teen stops the medicine?

As with stopping treatment for any other chronic condition, the underlying issue tends to return. For example, stopping a blood pressure medication usually leads blood pressure to rise again. In the same way, when a GLP-1 is discontinued, weight usually comes back. In adults who stopped semaglutide, about two-thirds of the lost weight returned within a year, and early teen data shows the same pattern. How much and how quickly weight returns varies from person to person. This is why doctors treat obesity as a long-term condition, and why stopping the medicine without medical advice is discouraged.

How do I talk to my teen about this without hurting their body image?

Use people-first, blame-free language and focus on overall mental and physical health, not appearance. Ask open questions, involve your teen in the decision, and never frame it as punishment or their fault.

What does it cost?

The Blueberry Balance subscription is $149 a month for clinical care. Medication is a separate cost, starting at $199 a month as of July 2026. For details, see our cost guide.

A note for families

This article is educational and is not a substitute for your pediatrician's individualized advice. Every teen is different, and the right choice depends on your child's full health. Always talk with your doctor about what is best for your teen.

Sources

American Academy of Pediatrics, 2023 Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity (Executive Summary): https://publications.aap.org/pediatrics/article/151/2/e2022060641/190440/

American Academy of Pediatrics and The Obesity Society, Stigma Experienced by Children and Adolescents With Obesity (Pediatrics 2017): https://publications.aap.org/pediatrics/article/140/6/e20173034/38277/

FDA, Wegovy Prescribing Information (pediatric 12+ indication; boxed warning; contraindications; pediatric use), rev. 03/2026: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s029lbl.pdf

FDA, News release on Saxenda approval for ages 12 and older (Dec 2020): https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-weight-management-drug-patients-aged-12-and-older

Eli Lilly, Zepbound Prescribing Information (not established under 18): https://pi.lilly.com/us/zepbound-uspi.pdf

Weghuber D, et al. Once-Weekly Semaglutide in Adolescents with Obesity, NEJM 2022;387:2245-2257 (STEP TEENS): https://www.nejm.org/doi/full/10.1056/NEJMoa2208601

Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: STEP 1 trial extension, Diabetes Obes Metab 2022: https://pmc.ncbi.nlm.nih.gov/articles/PMC9542252/

CDC, Evaluation and Treatment for Child Obesity: https://www.cdc.gov/obesity/child-obesity-strategies/evaluation-and-treatment.html